Former Tobira Executive Helen Jenkins Joins Alkahest as COO

Xconomy San Francisco — 

San Carlos, CA-based drug developer Alkahest has appointed Helen Jenkins as chief operating officer. Jenkins served in the same role at Tobira Therapeutics, a South San Francisco, CA, biotech that was acquired last year by Allergan (NYSE: AGN). Alkahest is developing treatments for neurodegenerative diseases and other age-related conditions.